Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Total Current Liabilities (2022 - 2025)

Neuraxis (NRXS) has disclosed Total Current Liabilities for 4 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 14.74% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2025, up 14.74% year-over-year, with the annual reading at $2.8 million for FY2025, 14.74% up from the prior year.
  • Total Current Liabilities hit $2.8 million in Q4 2025 for Neuraxis, down from $3.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $11.4 million in Q2 2023 to a low of $1.9 million in Q4 2023.
  • Historically, Total Current Liabilities has averaged $4.1 million across 4 years, with a median of $2.7 million in 2024.
  • Biggest five-year swings in Total Current Liabilities: tumbled 72.98% in 2023 and later increased 29.04% in 2024.
  • Year by year, Total Current Liabilities stood at $7.0 million in 2022, then crashed by 72.98% to $1.9 million in 2023, then grew by 29.04% to $2.4 million in 2024, then rose by 14.74% to $2.8 million in 2025.
  • Business Quant data shows Total Current Liabilities for NRXS at $2.8 million in Q4 2025, $3.1 million in Q3 2025, and $2.3 million in Q2 2025.